Personalized Disease Modeling for Rare Genetic Myopathies
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07914049. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to learn how rare genetic muscle diseases change over time and whether muscle cells grown from a participant's blood can help researchers understand the disease. The study will include children and young adults under age 21 with a genetic muscle disease and a rare genetic change that may be suitable for a future personalized treatment. The main questions are: How do each participant's muscle strength, movement, and health change over time? Can muscle cells grown from a participant's blood show how their genetic change affects muscle? For some participants, can a potential treatment improve those cells in the laboratory? Participants will be followed for approximately 2 years. Researchers will review their health, measure muscle function, and ask participants and caregivers about quality of life. Assessments may also include blood tests, muscle ultrasound, muscle MRI without sedation, optional nerve and muscle electrical measurements, and ankle-worn movement sensors for participants who walk. Researchers will use a blood sample to grow muscle cells in the laboratory to better understand how a muscle condition develops and what potential treatments might work.
Study identification
- NCT ID
- NCT07914049
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 22, 2026 (Actual)
- Primary completion
- Dec 2028 (Estimated)
- Completion
- Dec 2028 (Estimated)
- Last update posted
- Nov 3, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Akron Children's Hospital | Akron | Ohio | 44308 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07914049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.